EX-99.2 3 u56072exv99w2.htm EX-99.2 exv99w2
Exhibit 99.2
ASML — Summary U.S. GAAP Consolidated Statements of Operations1,4
                                 
    Three months ended,     Six months ended,  
(in thousands EUR, except per share data)   Jul 1, 2007     Jun 29, 2008     Jul 1, 2007     Jun 29, 2008  
 
Net system sales
    825,817       725,586       1,673,192       1,545,572  
Net service and field option sales
    104,405       118,571       205,700       217,793  
 
Total net sales
    930,222       844,157       1,878,892       1,763,365  
 
                               
Cost of sales
    546,956       506,689       1,103,808       1,052,271  
 
Gross profit on sales
    383,266       337,468       775,084       711,094  
 
                               
Research and development costs, net of credits
    120,310       130,241       236,752       258,500  
Amortization of in process R&D
                23,148        
Selling, general and administrative costs
    56,396       56,368       112,726       113,695  
 
Income from operations
    206,560       150,859       402,458       338,899  
 
                               
Interest income
    8,170       6,372       18,430       10,573  
 
Income from operations before income taxes
    214,730       157,231       420,888       349,472  
 
                               
Benefit from (provision for) income taxes
    (55,225 )     34,746       (108,708 )     (12,372 )
 
Net income
    159,505       191,977       312,180       337,100  
 
                               
Basic net income per ordinary share
    0.34       0.45       0.66       0.78  
Diluted net income per ordinary share
    0.33  2,3     0.44  3     0.64  2,3     0.78  3
 
                               
Number of ordinary shares used in computing per share amounts (in thousands):        
Basic
    470,395       431,221       471,984       431,412  
Diluted
    499,436  2,3     434,585  3     501,063  2,3     434,819  3
ASML — Ratios and Other Data1,4
                                 
    Three months ended,     Six months ended,  
    Jul 1, 2007     Jun 29, 2008     Jul 1, 2007     Jun 29, 2008  
 
Gross profit as a % of net sales
    41.2       40.0       41.3       40.3  
Income from operations as a % of net sales
    22.2       17.9       21.4       19.2  
Net income as a % of net sales
    17.1       22.7       16.6       19.1  
Shareholders’ equity as a % of total assets
    47.3       49.7       47.3       49.7  
Income taxes as a % of income before income taxes
    25.7       (22.1 )     25.8       3.5  
Sales of systems total (in units)
    69       39       146       89  
ASP of systems sales (EUR million)
    12.0       18.6       11.5       17.4  
Value of backlog systems total (EUR million)
    1,745       1,106       1,745       1,106  
Backlog systems total (in units)
    109       59       109       59  
ASP of backlog systems (EUR million)
    16.0       18.8       16.0       18.8  
Value of bookings systems total (EUR million)
    399       632       1,310       944  
Net bookings total (in units)
    30       33       92       59  
ASP of bookings systems (EUR million)
    13.3       19.2       14.2       16.0  
Number of employees
    6,213       6,821       6,213       6,821  

 


 

ASML — Summary U.S. GAAP Consolidated Balance Sheets1,4
                 
(in thousands EUR)   Dec 31, 2007     Jun 29, 2008  
 
ASSETS
               
Cash and cash equivalents
    1,271,636       1,360,898  
Accounts receivable, net
    637,975       516,886  
Inventories, net
    1,102,210       1,130,239  
Deferred tax assets short-term
    73,019       69,799  
Other current assets
    234,529       262,207  
 
Total current assets
    3,319,369       3,340,029  
 
               
Deferred tax assets long-term
    141,032       157,647  
Other assets
    59,991       39,342  
Goodwill
    128,271       119,823  
Other intangible assets, net
    38,195       30,062  
Property, plant and equipment, net
    380,894       458,100  
 
Total assets
    4,067,752       4,145,003  
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities
    1,321,437       1,247,315  
Deferred tax and other liabilities
    245,415       227,005  
Other deferred liabilities
    7,936       18,529  
Other long-term debt
    602,016       591,579  
 
Total liabilities
    2,176,804       2,084,428  
Shareholders’ equity
    1,890,948       2,060,575  
 
Total liabilities and shareholders’ equity
    4,067,752       4,145,003  

 


 

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows1,4
                                 
    Three months ended,     Six months ended,  
(in thousands EUR)   Jul 1, 2007     Jun 29, 2008     Jul 1, 2007     Jun 29, 2008  
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                               
Net income
    159,505       191,977       312,180       337,100  
 
                               
Depreciation and amortization
    24,157       26,545       77,519       57,121  
Disposal of property, plant and equipment
    9,923       1,311       10,874       2,414  
Share-based payments
    4,362       3,109       6,667       6,675  
Change in tax assets and liabilities
    10,838       (114,110 )     29,580       (92,313 )
Change in assets and liabilities
    62,953       21,145       9,942       86,331  
 
Net cash provided by operating activities
    271,738       129,977       446,762       397,328  
CASH FLOWS FROM INVESTING ACTIVITIES:
                               
Purchases of property, plant and equipment
    (39,723 )     (65,441 )     (75,512 )     (120,473 )
Proceeds from sale of property, plant and equipment
                3,355        
Acquisition of subsidiary (net of cash acquired)
                (188,011 )      
 
Net cash used in investing activities
    (39,723 )     (65,441 )     (260,168 )     (120,473 )
CASH FLOWS FROM FINANCING ACTIVITIES:
                               
Purchase of shares in conjunction with conversion rights of bond holders and stock options
                (156,253 )     (87,603 )
Dividend paid
          (107,447 )           (107,447 )
Net proceeds from issuance of shares and stock options
    10,546       552       21,041       3,528  
Net proceeds from issuance of bonds
    593,790             593,790        
Excess tax benefits from stock options
    194       5,969       836       5,971  
Redemption and/or repayment of debt
    (111 )           (345 )      
 
Net cash provided by (used in) financing activities
    604,419       (100,926 )     459,069       (185,551 )
 
Net cash flows
    836,434       (36,390 )     645,663       91,304  
Effect of changes in exchange rates on cash
    (387 )      144       (2,261 )     (2,042 )
 
Net increase (decrease) in cash & cash equivalents
    836,047       (36,246 )     643,402       89,262  

 


 

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations1,4
                                         
    Three months ended,  
    Jul 1,     Sep 30,     Dec 31,     Mar 30,     Jun, 29  
(in millions EUR)   2007     2007     2007     2008     2008  
 
Net system sales
    825.8       843.2       834.8       820.0       725.6  
Net service and field option sales
    104.4       91.2       120.1       99.2       118.6  
 
Total net sales
    930.2       934.4       954.9       919.2       844.2  
 
                                       
Cost of sales
    546.9       549.4       565.3       545.6       506.7  
 
Gross profit on sales
    383.3       385.0       389.6       373.6       337.5  
 
                                       
Research and development costs, net of credits
    120.3       120.1       129.3       128.3       130.2  
Selling, general and administrative costs
    56.4       56.0       56.9       57.3       56.4  
 
Income from operations
    206.6       208.9       203.4       188.0       150.9  
 
                                       
Interest income
    8.1       9.5       5.5       4.2       6.4  
 
Income from operations before income taxes
    214.7       218.4       208.9       192.2       157.3  
 
                                       
Benefit from (provision for) income taxes
    (55.2 )     (52.1 )     (8.1 )     (47.1 )     34.7  
 
Net income
    159.5       166.3       200.8       145.1       192.0  
ASML — Quarterly Summary Ratios and other data1,4
                                         
    Three months ended,  
    Jul 1,     Sep 30,     Dec 31,     Mar 30,     Jun 29,  
    2007     2007     2007     2008     2008  
 
Gross profit as a % of net sales
    41.2       41.2       40.8       40.6       40.0  
Income from operations as a % of net sales
    22.2       22.4       21.3       20.5       17.9  
Net income as a % of net sales
    17.1       17.8       21.0       15.8       22.7  
Shareholders’ equity as a % of total assets
    47.3       35.7       46.5       44.5       49.7  
Income taxes as a % of income before income taxes
    25.7       23.9       3.9       24.5       (22.1 )
Sales of systems total (in units)
    69       59       55       50       39  
ASP of system sales (EUR million)
    12.0       14.3       15.2       16.4       18.6  
Value of backlog systems total (EUR million)
    1,745       1,769       1,697       1,167       1,106  
Backlog systems total (in units)
    109       90       89       65       59  
ASP of backlog systems (EUR million)
    16.0       19.7       19.1       18.0       18.8  
Value of booking systems total (EUR million)
    399       857       803       312       632  
Net bookings total (in units)
    30       40       54       26       33  
ASP of bookings systems (EUR million)
    13.3       21.4       14.9       12.0       19.2  
Number of employees
    6,213       6,403       6,582       6,765       6,821  

 


 

ASML — Summary U.S. GAAP Consolidated Balance Sheets1,4
                                         
    Jul 1,     Sep 30,     Dec 31,     Mar 30,     Jun 29,  
(in millions EUR)   2007     2007     2007     2008     2008  
 
ASSETS
                                       
Cash and cash equivalents
    2,299.2       2,445.2       1,271.6       1,397.1       1,360.9  
Accounts receivable, net
    567.8       611.7       638.0       741.5       516.9  
Inventories, net
    972.9       1,021.2       1,102.2       1,152.0       1,130.2  
Deferred tax assets short-term
    131.8       131.3       73.0       71.1       69.8  
Other current assets
    183.7       214.2       234.6       267.6       262.2  
 
Total current assets
    4,155.4       4,423.6       3,319.4       3,629.3       3,340.0  
 
                                       
Deferred tax assets long-term
    203.0       143.5       141.0       135.8       157.7  
Other assets
    43.0       39.9       60.0       85.7       39.3  
Goodwill
    140.2       133.4       128.3       119.7       119.8  
Other intangible assets, net
    49.7       44.2       38.2       32.5       30.1  
Property, plant and equipment, net
    313.5       343.3       380.9       401.4       458.1  
 
Total assets
    4,904.8       5,127.9       4,067.8       4,404.4       4,145.0  
LIABILITIES AND SHAREHOLDERS’ EQUITY
                                       
Current liabilities
    1,331.2       2,391.5       1,321.4       1,562.3       1,247.3  
Deferred tax and other liabilities
    273.6       248.3       245.4       261.5       227.0  
Other deferred liabilities
    8.2       8.2       8.0       7.1       18.5  
Convertible subordinated debt
    380.0       44.5                    
Other long-term debt
    593.8       604.0       602.0       615.3       591.6  
 
Total liabilities
    2,586.8       3,296.5       2,176.8       2,446.2       2,084.4  
Shareholders’ equity
    2,318.0       1,831.4       1,891.0       1,958.2       2,060.6  
 
Total liabilities and shareholders’ equity
    4,904.8       5,127.9       4,067.8       4,404.4       4,145.0  

 


 

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows1,4
                                         
    Three months ended,  
    Jul 1,     Sep 30,     Dec 31,     Mar 30,     Jun 29,  
(in millions EUR)   2007     2007     2007     2008     2008  
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                                       
Net income
    159.5       166.3       200.8       145.1       192.0  
 
                                       
Depreciation and amortization
    24.1       28.0       29.8       30.6       26.5  
Disposal of property, plant and equipment
    9.9       1.7       1.6       1.1       1.3  
Share-based payments
    4.4       3.7       6.2       3.5       3.1  
Change in tax assets and liabilities
    10.8       (5.3 )     (0.6 )     21.8       (114.1 )
Change in assets and liabilities
    63.0       (20.1 )     (157.9 )     65.2       21.2  
 
Net cash provided by operating activities
    271.7       174.3       79.9       267.3       130.0  
CASH FLOWS FROM INVESTING ACTIVITIES:
                                       
Purchases of property, plant and equipment
    (39.7 )     (49.7 )     (54.0 )     (55.0 )     (65.5 )
Proceeds from sale of property, plant and equipment
                1.7              
 
Net cash used in investing activities
    (39.7 )     (49.7 )     (52.3 )     (55.0 )     (65.5 )
CASH FLOWS FROM FINANCING ACTIVITIES:
                                       
Capital repayment
                (1,011.9 )            
Purchase of shares in conjunction with conversion rights of bond holders and stock options
                (203.6 )     (87.6 )      
Dividend paid
                            (107.4 )
Net proceeds from issuance of shares and stock options
    10.5       19.5       22.8       3.0       0.5  
Net proceeds from issuance of bonds
    593.8                          
Excess tax benefits from stock options
    0.2       6.2       1.9             6.0  
Redemption and/or repayment of debt
    (0.1 )     (1.5 )     (7.8 )            
 
Net cash provided by (used in) financing activities
    604.4       24.2       (1,198.6 )     (84.6 )     (100.9 )
 
Net cash flows
    836.4       148.8       (1,171.0 )     127.7       (36.4 )
Effect of changes in exchange rates on cash
    (0.4 )     (2.8 )     (2.6 )     (2.2 )     0.2  
 
Net increase (decrease) in cash & cash equivalents
    836.0       146.0       (1,173.6 )     125.5       (36.2 )

 


 

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements
Basis of Presentation
ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).
Principles of consolidation
The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.
Use of estimates
The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.
Recognition of revenues
ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.
For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

 


 

ASML — Reconciliation U.S. GAAP — IFRS1,4
Net income
                                 
    Three months ended,     Six months ended,  
(in thousands EUR)   Jul 1, 2007     Jun 29, 2008     Jul 1, 2007     Jun 29, 2008  
 
Net income under U.S. GAAP
    159,505       191,977       312,180       337,100  
Share-based payments (see Note 1)
    (108 )     245       14       (518 )
Capitalization of development costs (see Note 2)
    (2,701 )     18,649       19,981       40,330  
Convertible subordinated notes (see Note 3)
    (2,220 )           (4,396 )      
Income taxes (see Note 4)
          (380 )     (7,648 )     39  
 
Net income under IFRS
    154,476       210,491       320,131       376,951  
 
                               
Shareholders’ equity
                                         
    Jul 1,     Sep 30,     Dec 31,     Mar 30,     Jun 29,  
(in thousands EUR)   2007     2007     2007     2008     2008  
 
Shareholders’ equity under U.S. GAAP
    2,318,002       1,831,438       1,890,948       1,958,159       2,060,575  
Share-based payments (see Note 1)
    3,924       7,126       787       (3,420 )     (3,266 )
Capitalization of development costs (see Note 2)
    110,749       120,344       138,424       157,900       176,818  
Convertible subordinated notes (see Note 3)
    27,019       2,894                    
Income taxes (see Note 4)
                8,852       9,186       8,478  
 
Shareholders’ equity under IFRS
    2,459,694       1,961,802       2,039,011       2,121,825       2,242,605  
Notes to the reconciliation from U.S. GAAP to IFRS
Note 1 Share-based Payments
Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.
Under U.S. GAAP, until December 31, 2005, ASML accounted for stock option plans using the intrinsic value method in accordance with APB 25 “Accounting for stock issued to employees” and provided pro forma disclosure of the impact of the fair value method on net income and earnings per share in accordance with SFAS No. 123 “Accounting for Stock Based Compensation”. As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.
Note 2 Capitalization of development costs
Under IFRS, ASML applies IAS 38, “Intangible Assets”. During the second half of 2004, ASML made changes to its administrative systems in order to provide sufficient information to comply with IFRS beginning from January 1, 2005. Sufficient reliable information to account for capitalization of development expenditures under IFRS before January 1, 2005 is not available. Under IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.
Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

 


 

Note 3 Convertible Subordinated Notes
Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.
Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding. As of December 31, 2007 ASML has no Convertible Subordinated Notes outstanding.
Note 4 Income taxes
Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12, unrealized net income resulting from intercompany transactions that is eliminated from the carrying amount of assets on consolidation gives rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.
Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.
“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

 


 

1   All quarterly information in this press release is unaudited.
 
2   The calculation of diluted net income per ordinary share assumes conversion of our Subordinated Notes as such conversions would have a dilutive effect.
 
3   The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans as such exercises would have a dilutive effect.
 
4   As of January 1, 2008 ASML accounts for award credits offered to its customers as part of a volume purchase agreement using the deferred revenue model. Until December 31, 2007 the cost accrual method was used. This change in accounting policy was made because the deferred revenue model better reflects the business rationale. In addition the International Financial Reporting Interpretation Committee concludes in interpretation 13 (IFRIC 13 “Customer Loyalty Programmes”) that the deferred revenue model is the appropriate accounting treatment. Comparative figures for 2007 were adjusted to reflect this change in accounting policy. The impact of this change on equity as per January 1, 2007 amounted to EUR 8.1 million (decrease) and on net income for the year 2007 and the first quarter of 2008 amounted to EUR 8.6 million (decrease) and EUR 0.1 million (increase) respectively.